Source: The Lakeside, OR weather data displayed above is derived from the NOAA (National Oceanic and Atmospheric). Air quality and pollution data is derived from the EPA (United States Environmental Protection Agency).
DUBLIN, June 15, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN) announced today that the 510(k) Premarket Notification Application for the XEN Glaucoma Treatment System (consisting of the XEN45 Gel Stent and the XEN Injector) has been accepted for filing by the U.S. Food and Drug Administration (FDA).
Safety Information: The Food and Drug Administration (FDA) and permits the use of Simethicone as an ingredient in Over-the-Counter (OTC) antacid and antiflatulent products. Cosmetic Ingredient Review (CIR) has deferred evaluation of this ingredient because the safety has been assessed by FDA.